Neoadjuvant treatment strategies in resectable pancreatic cancer

A Lambert, L Schwarz, M Ducreux, T Conroy - Cancers, 2021 - mdpi.com
Simple Summary Only 10–20% of patients with newly diagnosed resectable pancreatic
adenocarcinoma have potentially resectable disease. Upfront surgery is the gold standard …

[HTML][HTML] Surgical management of pancreatic ductal adenocarcinoma: a narrative review

E Sarfaty, N Khajoueinejad, MG Zewde… - Translational …, 2023 - ncbi.nlm.nih.gov
Surgical management of pancreatic ductal adenocarcinoma: a narrative review - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Fully covered self‐expandable metallic stents versus plastic stents for preoperative biliary drainage in patients with pancreatic head cancer and the risk factors for post …

F Kozakai, T Ogawa, S Koshita, Y Kanno… - DEN …, 2024 - Wiley Online Library
Objectives Optimal stents for preoperative biliary drainage (PBD) for patients with possible
resectable pancreatic cancer remain controversial, and risk factors for post‐endoscopic …

Clinical effect of laparoscopic radical surgery combined with neoadjuvant chemotherapy in treating cervical cancer and its influence on postoperative complications …

W Gong, Y Liu - Journal of Healthcare Engineering, 2022 - Wiley Online Library
Background. Cervical cancer, the only gynecological malignancy for which a clear
pathogeny has been established, has an incidence rate only second to breast cancer …